32P BioSilicon

32P-labeled BioSilicon compound · pSiMedica Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 32P BioSilicon, covering 2006-06-29 to 2007-03-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma [Phase 2]